Haven't used Affimed yet?
Ask AI

Ask AI about Affimed

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Kevin Doheny
Reviews 1

Working at Affimed has been a rewarding experience. The company culture is inclusive and supportive, and the team is highly motivated and talented. I have had the opportunity to work on challenging projects and collaborate with experts in the field. The management team values employee input and provides opportunities for growth and development. Overall, I am very satisfied with my time at Affimed and would strongly recommend it.

Michiel Jongsma
Reviews 1

👍 I had the opportunity to visit Affimed last month and I must say, they are doing incredible work in the field of biotechnology. The team is passionate and dedicated, and their research is truly groundbreaking. I was impressed by the state-of-the-art facilities and the collaborative atmosphere. It's clear that Affimed values innovation and excellence. I look forward to seeing their future advancements and would highly recommend them to anyone interested in the biotech industry. 👏

Michael Bolognini
Reviews 1

I recently came across a company named Affimed through a friend. They seem to be doing some interesting work in the biotech industry. Their website affimed.com provides a lot of information about their research and development efforts. I am impressed with their focus on innovation and their commitment to developing new therapies. Although I have not personally interacted with the company, their reputation seems to be positive. I would definitely consider them as a potential employer or collaborator in the future.

Andrew Turner
Reviews 1

Affimed is doing incredible work in the biotech industry. Their dedication to innovation and improving patient outcomes is truly remarkable. The team is highly skilled and collaborative, creating an environment that fosters creativity and excellence. I am impressed with their cutting-edge research and their focus on developing novel therapies. I would highly recommend Affimed to anyone interested in working in the field of biotechnology.

Carl Schlachte
Reviews 1

As a biotechnology enthusiast, I have been following Affimed closely for some time now. Their groundbreaking research and innovative solutions have always impressed me. What sets Affimed apart is their commitment to improving patients' lives. I admire their dedication and the impact they are making in the field of biotechnology. Kudos to the entire team at Affimed for their exceptional work!

Wes Nur
Reviews 1

Affimed is an innovative company that is driving advancements in the field of biotechnology. Their dedication to improving patient outcomes is truly commendable. The team is highly skilled and collaborative, making it a great place to work. I appreciate the company's emphasis on research and development, and their commitment to bringing novel therapies to market. Overall, I am impressed with Affimed's work and look forward to seeing their continued progress.

Barbara Martinez
Reviews 1

🤩 I have been following Affimed's progress in the biotech industry and I must say, they are doing an exceptional job. Their research and development efforts are groundbreaking, and their commitment to innovation is inspiring. The team is passionate and dedicated, and it's clear that they are making a significant impact in the field. I am excited to see what the future holds for Affimed and I would highly recommend them to anyone interested in biotechnology. 🚀

Boyd Bailey
Reviews 1

😊 I recently had the pleasure of visiting Affimed, and I must say, it exceeded my expectations. The company's commitment to excellence is evident in every aspect of their work. The team is highly knowledgeable and passionate about what they do. The cutting-edge research and state-of-the-art facilities are a testament to their dedication to advancing biotechnology. I am excited to see what the future holds for Affimed and I highly recommend them.

Jesse Ojeda
Reviews 1

I started working at Affimed a few months ago and it has been a great experience so far. The company has a strong vision and is making a positive impact in the biotech industry. The team is talented and supportive, and the work environment is conducive to learning and growth. I appreciate the opportunities for professional development and the emphasis on work-life balance. Overall, I am happy to be a part of Affimed and I am excited about the future.

John Lucchese
Reviews 1

Affimed is a great company to work for. The company culture is excellent and the employees are supportive and collaborative. The management team is transparent and encourages innovation. The work-life balance is also great and the benefits are competitive. Overall, I am very satisfied with Affimed and would highly recommend it to others.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="affimed" data-lang="en"></div>
More widgets

About Affimed

Affimed (AFMD) is pioneering a transformative innate immunity therapeutic approach to eradicating solid and hematologic tumors to help patients fight cancer.

Affimed: Pioneering a Transformative Innate Immunity Therapeutic Approach to Eradicating Cancer

Affimed (AFMD) is a biopharmaceutical company that is dedicated to developing innovative cancer treatments. The company's mission is to eradicate solid and hematologic tumors by pioneering a transformative innate immunity therapeutic approach. Affimed's cutting-edge technology platform, known as ROCK® (Redirected Optimized Cell Killing), enables the development of highly specific and potent immunotherapies that can target cancer cells while sparing healthy tissues.

The ROCK® platform leverages the power of natural killer (NK) cells, which are part of the body's innate immune system. NK cells are able to recognize and kill infected or abnormal cells without prior exposure or activation, making them an ideal candidate for cancer therapy. However, NK cells have limited efficacy against solid tumors due to their inability to penetrate the tumor microenvironment and overcome immunosuppressive mechanisms.

Affimed has developed a unique approach that overcomes these limitations by engineering NK cell engagers that can selectively bind both tumor antigens and NK cell receptors. This dual binding mechanism activates NK cells specifically at the site of the tumor, leading to targeted killing of cancer cells while sparing healthy tissues.

One example of Affimed's innovative technology is AFM13, an investigational drug candidate for Hodgkin lymphoma (HL) and other CD30-positive malignancies. AFM13 is designed to engage both CD16A on NK cells and CD30 on tumor cells, leading to selective killing of malignant HL cells while sparing normal tissue.

Another promising drug candidate in Affimed's pipeline is AFM24, which targets EGFR-expressing solid tumors such as lung cancer and head-and-neck squamous cell carcinoma (HNSCC). AFM24 binds both EGFR on tumor cells and CD16A on NK cells, leading to targeted destruction of malignant tissue.

In addition to its proprietary ROCK® platform, Affimed has established collaborations with leading pharmaceutical companies such as Roche/Genentech, Merck KGaA/EMD Serono, Takeda/Millennium Pharmaceuticals Inc., Astellas Pharma Inc., MD Anderson Cancer Center at University of Texas in Houston TX USA ,and others . These partnerships enable Affimed access cutting-edge technologies such as bispecific antibodies or CAR-Ts for combination therapies with its own products .

Overall ,the company has built a robust pipeline with multiple clinical-stage programs targeting various types of cancers including blood cancers like Hodgkin lymphoma , Non-Hodgkin Lymphoma , Acute Myeloid Leukemia etc..as well as solid tumors like lung cancer , HNSCC etc..

In conclusion,Affirmed represents an exciting opportunity in the field of oncology research with its innovative approach towards eradicating solid and hematologic tumors using natural killer cell engagers . With its strong pipeline backed by strategic collaborations with industry leaders,the company holds great potential for delivering transformative therapies that could change lives for patients fighting against this deadly disease .

Categories
Biotechnology